Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Moore

Showing results (201-210 of 235) with videos related to

Pageof 24
Sort By:
British Journal of Cancer|November 3, 2005
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerS P Ackland, M Jones, D Tu, et al.
The Journal of Experimental Medicine|October 1, 1990
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus bindingD Healey, L Dianda, J P Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsA Patnaik, E Warner, M Michael, et al.
ACS Applied Materials & Interfaces|April 27, 2026
3D-Printed, Ultrastretchable Polychloroprene Elastomers via Thiol-ene PhotopolymerizationLevi M J Moore, Maren E Summers, Ashley M Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end pointsD J Bloomfield, M D Krahn, T Neogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeksL L Siu, A M Oza, E A Eisenhauer, et al.
Diseases of Aquatic Organisms|October 17, 2014
Decompression sickness ('the bends') in sea turtlesD García-Párraga, J L Crespo-Picazo, Y Bernaldo de Quirós, et al.
British Journal of Cancer|March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancerC A Townsley, P Major, L L Siu, et al.
Advances in Therapy|May 29, 2009
Investigation of a multimarker approach to the initial assessment of patients with acute chest painC J McCann, B M Glover, I B A Menown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC M Canil, M J Moore, E Winquist, et al.
Pageof 24

Showing results (201-210 of 235) with videos related to

Sort By:
Pageof 24
British Journal of Cancer|November 3, 2005
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerS P Ackland, M Jones, D Tu, et al.
The Journal of Experimental Medicine|October 1, 1990
Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus bindingD Healey, L Dianda, J P Moore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumorsA Patnaik, E Warner, M Michael, et al.
ACS Applied Materials & Interfaces|April 27, 2026
3D-Printed, Ultrastretchable Polychloroprene Elastomers via Thiol-ene PhotopolymerizationLevi M J Moore, Maren E Summers, Ashley M Robinson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Economic evaluation of chemotherapy with mitoxantrone plus prednisone for symptomatic hormone-resistant prostate cancer: based on a Canadian randomized trial with palliative end pointsD J Bloomfield, M D Krahn, T Neogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeksL L Siu, A M Oza, E A Eisenhauer, et al.
Diseases of Aquatic Organisms|October 17, 2014
Decompression sickness ('the bends') in sea turtlesD García-Párraga, J L Crespo-Picazo, Y Bernaldo de Quirós, et al.
British Journal of Cancer|March 30, 2006
Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancerC A Townsley, P Major, L L Siu, et al.
Advances in Therapy|May 29, 2009
Investigation of a multimarker approach to the initial assessment of patients with acute chest painC J McCann, B M Glover, I B A Menown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials GroupC M Canil, M J Moore, E Winquist, et al.
Pageof 24